Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of primary chemotherapy duration with or without endocrine therapy in locally advanced breast cancer
2008-006383-10Phase 2Completed
- Sponsor
- European Institute of Oncology
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of vinorelbine, fluorouracil, cisplatin, letrozole and triptorelin in breast cancer (2 arms), sponsored by European Institute of Oncology. Primary endpoint: Ki-67 expression change. Started Dec 2008; status: completed.
02
Drugs
vinorelbinefluorouracilcisplatinletrozoletriptorelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-006383-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006383-10.